Editas Medicine Inc (EDIT)
1.37
-0.08
(-5.52%)
USD |
NASDAQ |
Jan 08, 10:38
Editas Medicine Research and Development Expense (Quarterly): 47.64M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 219.76M |
| Johnson & Johnson | 4.952B |
| Pfizer Inc | 2.598B |
| Revvity Inc | 49.14M |
| Kodiak Sciences Inc | 31.88M |